Rhizobacterial mediated antimetabolites and their significant effect on human pathogens
Abstract
Background: The emergence of antibiotic resistant bacteria is increasing globally. Therefore, new strategies and exploration of new metabolites are need of the day to combat various diseases. The aim of the current study is to isolate the rhizobacterial strains from medicinal plants to examine their antibacterial activity against human pathogens.
Methods: The total 239 rhizobacterial isolates were screened with agar plug and well diffusion methods, characterized biochemically and identified by Bergey’s manual scheme. In chemical screening, metabolic extracts of rhizobacterial isolates were separated in thin layer chromatography (TLC) and further identified by HPLC. The ability of rhizobacterial strains for optimum metabolite production was checked in vitro under different environmental conditions.
Results: Results showed that 31% isolates had antibacterial activity against Bacillus cereus, Bacillus subtilis, E. coccus, E. coli, Salmonella, Klebsiella, Staphylococcus aureus ATCC20737, Staphylococcus aureus ATCC25923 and Neisseria. Gonorrhea ATCC19424, methicillin resistant Staphylococcus aureus 1, methicillin resistant Staphylococcus aureus 6 and methicillin resistant Staphylococcus aureus 8. Maximum rhizobacterial strains showed best antibacterial activity at 35ᵒC and at pH7. ST5 strain showed significant results against E. coli ETCC and methicillin resistant Staphylococcus aureus-7 (25mm zone of inhibition). The bands of ST5 and ST2 extracts on a TLC plate were detected at Rf value 4.7 and 4.8 respectively. In HPLC, different peaks at different retention times with maximum peak at 2.90 and 2.92 indicating the production of antimetabolites.
Conclusion: These rhizobacterial isolates are valuable inputs in natural consortium to produce specific antibacterial metabolites. Demonstrating the structure and purification of these bioactive compounds may enhance the antimicrobial activities which further can be helpful in development of antibiotics.
Keywords: Antibiotics; Rhizobacteria; Antimicrobial agents; MRSA; HPLC
Full Text:
PDFReferences
Bardgett, Richard D, and Wim H. Van Der Putten. Belowground biodiversity and ecosystem functioning. Nature, (2014);752: 7528-505.
Köberl M, Schmidt R, Ramadan EM, Bauer R, Berg G. The microbiome of medicinal plants: diversity and importance for plant growth, quality and health. Frontiers in microbiology, (2013); 4: 400.
Mahler HC, Friess W, Grauschopf U, Kiese S. Protein aggregation: pathways, induction factors and analysis. Journal of pharmaceutical sciences,(2009); 9: 2909-2934.
Pandey A, Malviya T. Production of antibiotics isolated from soil bacteria from rhizospheric and non-rhizospheric region of medicinal plants. Indian journal of applied research, (2014);8: 25-32.
Abada EA, El-Hendawy HH, Osman ME, Hafez MA. Antimicrobial activity of Bacillus circulans isolated from rhizosphere of Medicago sativa. Life Science Journal,(2014); 8: 711-719.
Marasini, B. P, Baral, P, Aryal, P., Ghimire, K. R., Neupane, S., Dahal, N, and Shrestha, K. Evaluation of antibacterial activity of some traditionally used medicinal plants against human pathogenic bacteria. BioMed research international, (2015);6. https://doi.org/10.1155/2015/265425
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical infectious diseases, (2009);1: 1-12.
Aslam S, Sajid I. Antimicrobial potential of Halophilic actinomycetes against multi drug resistant (MDR) ventilator associated pneumonia causing bacterial pathogens. Pakistan journal of pharmaceutical sciences,(2016); 2:367-374.
Köberl M, Schmidt R, Ramadan EM, Bauer R, Berg G. The microbiome of medicinal plants: diversity and importance for plant growth, quality and health. Frontiers in microbiology,(2013); 4: 400.
Bibi F. Diversity of antagonistic bacteria isolated from medicinal plant Peganum harmala L. Saudi journal of biological sciences,(2017); 6: 1288-1293.
Cappuccino, James G., Natalie Sherman, and A. Microbiology. A laboratory manual. (1983): 315-317.
Aftab U, Zechel DL, Sajid I. Antitumor compounds from Streptomyces sp. KML-2, isolated from Khewra salt mines, Pakistan. Biological research, (2015); DOI:10.1186/s40659-015-0046-3
El Euch IZ, Frese M, Sewald N, Smaoui S, Shaaban M, Mellouli L. Bioactive secondary metabolites from a new terrestrial Streptomyces sp. TN262. Applied biochemistry and biotechnology, (2010); 2: 579-593.
Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. Journal of pharmaceutical analysis,(2016); 2: 71-79.
Hahn-Deinstrop, E. Applied thin-layer chromatography: best practice and avoidance of mistakes. John Wiley and Sons (2007);.1-15.
Banin E, Hughes D, Kuipers OP. Bacterial pathogens, antibiotics and antibiotic resistance. FEMS microbiology reviews,(2017);3: 450-452.
Piña B, Bayona JM, Christou A, Fatta-Kassinos D, Guillon E, et al. On the contribution of reclaimed wastewater irrigation to the potential exposure of humans to antibiotics, antibiotic resistant bacteria and antibiotic resistance genes–NEREUS COST Action ES1403 position paper. Journal of Environmental Chemical Engineering, (2018); 102-131.
Kumar S, Das G, Shin HS, Patra JK. Dioscorea spp. (a wild edible tuber): a study on its ethnopharmacological potential and traditional use by the local people of Similipal Biosphere Reserve, India. Frontiers in pharmacology, (2017); doi: 10.3389/fphar.2017.00052
Raj Y, Chauhan VS. Isolation, characterization and screening of novel antibiotic producing bacteria from natural habitats of Western Himalayas and industrial waste soil samples. International Journal of Computer Systems,(2019); 3: 3282-3288.
Damle S, Sharon K. Antioxidant activity, TLC and HPLC-ESI-Q-TOF-MS fingerprinting of Catunaregam spinosa (Thunb.) triveng. Journal of Pharmacognosy and Phytochemistry,(2018);4: 2119-2124.
DOI: http://dx.doi.org/10.62940/als.v7i3.865
Refbacks
- There are currently no refbacks.